Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
202.70B
Market cap202.70B
Price-Earnings ratio
12.50
Price-Earnings ratio12.50
Dividend yield
3.95%
Dividend yield3.95%
Average volume
11.43M
Average volume11.43M
High today
$82.25
High today$82.25
Low today
$80.71
Low today$80.71
Open price
$80.98
Open price$80.98
Volume
12.64M
Volume12.64M
52 Week high
$119.38
52 Week high$119.38
52 Week low
$73.31
52 Week low$73.31

MRK News

Simply Wall St 10h
How Positive Trial Results for CAPVAXIVE and Ifinatamab Deruxtecan Will Impact Merck Investors

In recent days, Merck announced positive Phase 3 results for its CAPVAXIVE® pneumococcal vaccine in children and adolescents, and released encouraging clinical...

How Positive Trial Results for CAPVAXIVE and Ifinatamab Deruxtecan Will Impact Merck Investors
TipRanks 21h
Merck downgraded to Hold from Buy at Berenberg

Berenberg analyst Luisa Hector downgraded Merck (MRK) to Hold from Buy with a price target of $90, down from $100. The firm says the “error bars” on Merck’s lon...

Benzinga 2d
Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots

Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention’s Advisory Committee on I...

Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots

Analyst ratings

56%

of 27 ratings
Buy
55.6%
Hold
44.4%
Sell
0%

More MRK News

Simply Wall St 3d
Merck And Daiichi Sankyo's R-DXd Receives FDA Breakthrough Therapy Designation

experienced a 6% rise in its share price over the last quarter, coinciding with significant developments such as the FDA granting Breakthrough Therapy Designati...

Merck And Daiichi Sankyo's R-DXd Receives FDA Breakthrough Therapy Designation
Seeking Alpha 5d
Astra, Lilly are latest to reevaluate U.K. investments after Merck’s pullback: reports

AstraZeneca (AZN) and Eli Lilly (NYSE:LLY) have become the latest leading drugmakers to reconsider their investment options in the U.K. after Merck (MRK) cancel...

Astra, Lilly are latest to reevaluate U.K. investments after Merck’s pullback: reports
TipRanks 6d
AstraZeneca pauses planned $270M investment in Britain, Reuters reports

Britain’s biggest company AstraZeneca (AZN) has paused a planned $271.26M investment in its Cambridge research site, a spokesperson said, the latest drugmaker t...

Seeking Alpha 7d
Merck says trial data for pneumonia shot Capvaxive shows promise in younger people

Healthcare Merck says trial data for pneumonia shot Capvaxive shows promise in younger people Sep. 11, 2025 7:18 AM ET Merck & Co., Inc. (MRK) Stock By: Dulan L...

Merck says trial data for pneumonia shot Capvaxive shows promise in younger people
TipRanks 7d
Merck’s capvaxive shows positive immune response in pneumococcal disease

Merck (MRK) announced positive results from the Phase 3 STRIDE-13 trial evaluating capvaxive – Pneumococcal 21-valent Conjugate Vaccine – at the 6th European So...

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.